Business Description
Pomdoctor Ltd
ISIN : US73181R1086
Share Class Description:
POM: ADRTotal Employee Number:
165Description
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -4.22 | |||||
Debt-to-Equity | -1 | |||||
Debt-to-EBITDA | -3.86 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -33.32 | |||||
Beneish M-Score | -4.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 48.8 | |||||
3-Year EBITDA Growth Rate | -296.8 | |||||
3-Year EPS without NRI Growth Rate | -135.9 | |||||
3-Year FCF Growth Rate | -139.3 | |||||
3-Year Book Growth Rate | 44.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.33 | |||||
9-Day RSI | 38.58 | |||||
14-Day RSI | 37.55 | |||||
3-1 Month Momentum % | -59.7 | |||||
6-1 Month Momentum % | -69.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.48 | |||||
Quick Ratio | 0.44 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 8.28 | |||||
Days Sales Outstanding | 10.54 | |||||
Days Payable | 33.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.4 | |||||
Shareholder Yield % | -245.96 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.05 | |||||
Operating Margin % | -29.29 | |||||
Net Margin % | -53.25 | |||||
EBITDA Margin % | -29.7 | |||||
FCF Margin % | -37.37 | |||||
OCF Margin % | -37.37 | |||||
ROA % | -324.41 | |||||
ROIC % | -127.79 | |||||
3-Year ROIIC % | -210.85 | |||||
ROC (Joel Greenblatt) % | -17007.46 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.19 | |||||
EV-to-EBIT | -4.21 | |||||
EV-to-EBITDA | -4.21 | |||||
EV-to-Revenue | 1.25 | |||||
EV-to-FCF | -3.35 | |||||
Earnings Yield (Greenblatt) % | -23.75 | |||||
FCF Yield % | -189.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:POM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pomdoctor Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 56.307 | ||
| EPS (TTM) ($) | -4.108 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 37.55 | ||
| 14-Day ATR ($) | 0.426517 | ||
| 20-Day SMA ($) | 1.710319 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 1.168199 - 115.739999 | ||
| Shares Outstanding (Mil) | 7.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pomdoctor Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pomdoctor Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-12-03 | In 157 days | ||
| Third quarter earnings results for 2026 | 2026-11-30 | In 154 days | ||
| General meeting for 2026 | 2026-07-17 | In 18 days | ||
| First quarter earnings results for 2026 | 2026-06-30 | In 1 day | ||
| 0.0555556:1 Stock Split | 2026-06-22 | 1.29 (-17.64%) | ||
| Annual report for 2025 | 2026-05-14 | 2.31 (-6.36%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-14 | 2.31 (-6.36%) | ||
| Second quarter earnings results for 2025 | 2025-12-03 | 83.88 (+1.75%) |
Show
Entries
Pomdoctor Ltd Frequently Asked Questions
What is Pomdoctor Ltd(POM)'s stock price today?
The current price of POM is $1.49. The 52 week high of POM is $115.74 and 52 week low is $1.17.
When is next earnings date of Pomdoctor Ltd(POM)?
The next earnings date of Pomdoctor Ltd(POM) is 2026-06-30 Est..
Does Pomdoctor Ltd(POM) pay dividends? If so, how much?
Pomdoctor Ltd(POM) does not pay dividend.
Guru Commentaries on NAS:POM
No articles.
Press Release
Articles on Pomdoctor Ltd
No articles.
Headlines
See More- 1
Jun 17, 2026
Pomdoctor finalizes June 22 effective date for 1-for-18 reverse ADS split
Seeking Alpha • 6:08am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers